Table 2. Incidence of common toxicities with the FOLFIRI and FOLFOXIRI regimens (maximum toxicity per patient).
FOLFIRI (146) | FOLFOXIRI (130) | FOLFIRI (146) | FOLFOXIRI (130) | |||
---|---|---|---|---|---|---|
Any
|
Grade 3/4
|
|||||
% | % | P-value | % | % | P-value | |
Neutropenia | 60 | 73 | NSa | 28 | 35 | 0.192 |
Febrile neutropenia | 6 | 9 | NS | 4 | 7 | 0.186 |
Thrombocytopenia | 20 | 31 | NS | 4 | 2 | 0.4 |
Anaemia | 59 | 60 | NS | 1 | 4 | 0.072 |
Nause/vomiting | 45 | 52 | NS | 4.8 | 4.6 | 0.944 |
Diarrhoea | 51 | 69 | NS | 10.9 | 27.7 | 0.0001 |
Mucocitis | 18 | 21 | NS | 4 | 5 | 0.748 |
Neurological | 11 | 59 | 0.001 | 0 | 5.8 | 0.001 |
Cutaneous | 15 | 21 | NS | 3 | 4 | 0.133 |
Alopecia | 56 | 74 | NS | 12 | 32 | 0.0001 |
Fatigue | 36 | 41 | NS | 5 | 5.6 | 0.944 |
NS, nonsignificant.